Publication Category: Metabolic Health
Impaired metabolic health over-time and high abdominal fat are prospectively associated with high-sensitivity C-reactive protein in children: The IDEFICS study
- E. M. González-Gil; L. A. Moreno; A. Nappo; J. Santabárbara; M. Wolters; P. Russo; S. De Henauw; T. Veidebaum; D. Molnar; M. Hunsberger; A. Fraterman; L. Iacoviello; M. Tornaritis; W. Ahrens; S. Bel-Serrat Impaired metabolic health over-time and high abdominal fat are prospectively associated with high-sensitivity C-reactive protein in children: The IDEFICS study Pediatr Obes
APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
- R. Fallaize; A. L. Carvalho-Wells; A. C. Tierney; C. Marin; B. Kieć-Wilk; A. Dembińska-Kieć; C. A. Drevon; C. DeFoort; J. Lopez-Miranda; U. Risérus; W. H. Saris; E. E. Blaak; H. M. Roche; J. A. Lovegrove APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome Scientific reports
Genetics and the metabolic syndrome
- E. Fanning; D. O'Shea Genetics and the metabolic syndrome Clin Dermatol
A period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome
- A. Garcia-Rios; P. Perez-Martinez; J. Delgado-Lista; C. M. Phillips; I. M. F. Gjelstad; J. W. Wright; B. Karlström; B. Kiéc-Wilk; A. M. J. van Hees; O. Helal; A. Polus; C. Defoort; U. Riserus; E. E. Blaak; J. A. Lovegrove; C. A. Drevon; H. M. Roche; J. Lo A period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome Journal of Nutrition
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
- J. A. Elliott; J. V. Reynolds Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol
Visceral obesity, metabolic syndrome, insulin resistance and cancer
- S. L. Doyle; C. L. Donohoe; J. Lysaght; J. V. Reynolds Visceral obesity, metabolic syndrome, insulin resistance and cancer Proc Nutr Soc
Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma
- S. L. Doyle; A. M. Mongan; C. L. Donohoe; G. P. Pidgeon; M. Sherlock; J. V. Reynolds; J. Lysaght Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma Dis Esophagus
Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent
- J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome
- J. Delgado-Lista; P. Perez-Martinez; A. Garcia-Rios; C. M. Phillips; W. Hall; I. M. F. Gjelstad; D. Lairon; W. Saris; B. Kieć-Wilk; B. Karlström; C. A. Drevon; C. Defoort; E. E. Blaak; A. Dembinska-Kieć; U. Risérus; J. A. Lovegrove; H. M. Roche; J. Lopez- A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome Nutrition, Metabolism and Cardiovascular Diseases